Myanmar vs Rwanda: Cause of death, by non-communicable diseases, ages 0-4
Myanmar
13.2%
in 2021
Rwanda
14.1%
in 2021
Myanmar rank
136th
Rwanda rank
133rd
Cause of death, by non-communicable diseases, ages 0-4 over time
- Myanmar
- Rwanda
How they compare
Rwanda currently reports 14.1% against 13.2% in Myanmar, a difference of 0.9%.
That makes Rwanda's figure about 1.1 times Myanmar's.
The two have swapped places 3 times across 6 shared years of data; in 2000 it was Myanmar ahead.
Myanmar ranks 136th and Rwanda ranks 133rd of 185 countries.
Myanmar has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Myanmar | Rwanda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10.0% | 4.3% | 5.7% | Myanmar |
| 2010s | 13.6% | 13.5% | 0.1% | Myanmar |
| 2020s | 14.5% | 14.5% | 0.0% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, Myanmar or Rwanda?
- Rwanda, at 14.1% against 13.2% in Myanmar as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4 between Myanmar and Rwanda?
- 0.9%, with Rwanda ahead.
- How many years of comparable data are there for Myanmar and Rwanda?
- 6 years are reported by both, from 2000 to 2021.
- How do Myanmar and Rwanda rank globally for cause of death, by non-communicable diseases, ages 0-4?
- Myanmar ranks 136th and Rwanda ranks 133rd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4 (% of total deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 0-4 due to non-communicable diseases divided by number of all deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.